PEDIATRICS Vol. 99 No. 4 April 1997, pp. 529-533 (doi:10.1542/peds.99.4.529)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serwint, J. R.
Right arrow Articles by Virden, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serwint, J. R.
Right arrow Articles by Virden, J. M.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 99 No. 4 April 1997, pp. 529-533

Outcomes of Annual Tuberculosis Screening by Mantoux Test in Children Considered to be at High Risk: Results From One Urban Clinic

Received Dec 7, 1995; accepted May 31, 1996.

Janet R. Serwint, Barbara S. Hall, Robert M. Baldwin, and Jane M. Virden

From the Department of Pediatrics, Johns Hopkins Children's Center, Baltimore, Maryland.

Background.  In January 1994, the American Academy of Pediatrics recommended that annual screening with the purified protein derivative tuberculin skin test, Mantoux method, be used for tuberculosis screening in high-risk children. This test has a better sensitivity and specificity than the previously used multiple puncture test, and patients need to return for a reading done by palpation by a health care professional.

Objective.  To estimate the prevalence of reactivity to purified protein derivative tuberculin in an urban primary care clinic whose patients meet high-risk criteria and to determine if annual screening is warranted, to determine the adherence to return to the clinic for reading of the skin test, and to describe the characteristics of patients who have tuberculosis infection and disease.

Research Design.  Cross-sectional study.

Setting.  Inner-city, hospital-based primary care pediatric clinic in Baltimore, MD.

Subjects.  A total of 1433 consecutive children attending this clinic from March through September, 1994, who were at risk for tuberculosis because of frequent exposure to poor and medically indigent city dwellers.

Methods.  The Mantoux test (5TU intradermal injection of purified protein derivative) was administered to children at annual health supervision visits. Patients were tracked to determine those who returned for a reading by a health care professional and find those with a positive Mantoux test. The charts of children with a positive test were reviewed.

Results.  Five hundred seventy-three (40%) patients returned for a reading by a health care professional. Five patients had a positive Mantoux test, giving a prevalence rate of 0.8% of reactivity to purified protein derivative tuberculin. One child with a positive Mantoux test also had chest radiograph findings consistent with tuberculosis disease but was asymptomatic.

Conclusions.  In our city with a low prevalence of disease, children whose only risk factor for tuberculosis was exposure to poor and medically indigent city dwellers did not represent a high-risk group. Our results are supportive of the 1996 American Academy of Pediatrics screening statement that annual screening is not warranted. Sixty percent of children did not return for a reading of the Mantoux test by a health care professional. Alternative strategies that are more convenient for parents are needed to obtain accurate readings by health care professionals when skin testing is deemed necessary.

Key words: tuberculosis infection, disease, pediatrics, children, screening, Mantoux, tuberculin skin test, PPD, high risk, urban, resident continuity clinic.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
J. Young and M. E. O'Connor
Risk Factors Associated With Latent Tuberculosis Infection in Mexican American Children
Pediatrics, June 1, 2005; 115(6): e647 - e653.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
S. Chang, L. S. M. Wheeler, and K. P. Farrell
Public Health Impact of Targeted Tuberculosis Screening in Public Schools
Am J Public Health, December 1, 2002; 92(12): 1942 - 1945.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
C. W. DeLago, N. D. Spector, B. Moughan, M. M. Moran, H. Kersten, and L. Smals
Collaboration With School Nurses: Improving the Effectiveness of Tuberculosis Screening
Arch Pediatr Adolesc Med, December 1, 2001; 155(12): 1369 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
P. O. Ozuah
A Successful Strategy for Increasing Adherence to Tuberculosis Test Reading in High-Risk Children
Arch Pediatr Adolesc Med, July 1, 2001; 155(7): 856 - 856.
[Full Text] [PDF]


Home page
PediatricsHome page
H. Froehlich, L. M. Ackerson, P. A. Morozumi, and the Pediatric Tuberculosis Study Group of Kaiser P
Targeted Testing of Children for Tuberculosis: Validation of a Risk Assessment Questionnaire
Pediatrics, April 1, 2001; 107(4): e54 - e54.
[Abstract] [Full Text] [PDF]